规范儿童肺间质疾病的治疗任重而道远  

It is challenging to standardize the treatment for children's interstitial lung diseases in China

作　　者：农光民[1] 赵顺英[2] 郑跃杰[3] 陈慧中[4] Nong Guangmin;Zhao Shunying;Zheng Yuejie;Chen Huizhong(Department of Pediatrics,the First Affiliated Hospital of Guangxi Medical University,Nanning 530021, China;Department of Respiratory Disease,Belting Children's Hospital,Capital Medical University,National Center for Children's Health,Beijing 100045,China;Department of Respiratory Disease,Shenzhen Children's Hospital,Shenzhen 518026,China;Department of Respiratory Medicine,Childrens'Hospital,Capital Institute of Pediatrics,Beijing 100020,China)

机构地区：[1]广西医科大学第一附属医院儿科,南宁530021 [2]首都医科大学附属北京儿童医院呼吸二科,100045 [3]深圳市儿童医院呼吸科,518026 [4]首都儿科研究所附属儿童医院呼吸科,北京100020

出　　处：《中华儿科杂志》2019年第1期3-4,共2页Chinese Journal of Pediatrics

摘　　要："儿童弥漫性肺实质疾病/肺间质疾病治疗建议"的制定,是一项既困难又颇具挑战性的工作,但治疗的规范化又是临床医生迫切需要的,尽管本次只是提供了专家观点相对一致的治疗原则,我们坚信今后一定能逐渐完善,再上一个台阶。

关 键 词：肺间质疾病 治疗原则 儿童 临床医生 专家观点 肺实质 弥漫性 

分 类 号：R725.6[医药卫生—儿科]